ANI PHARMACEUTICALS, INC (ANIP) Revenue 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$883.4MFY2025 · since FY2016: $128.6M → $883.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $883.4M | +43.8% |
| FY2024 | $614.4M | +26.2% |
| FY2023 | $486.8M | +53.9% |
| FY2022 | $316.4M | +46.4% |
| FY2021 | $216.1M | +3.7% |
| FY2020 | $208.5M | +0.9% |
| FY2019 | $206.5M | +2.5% |
| FY2018 | $201.6M | +14.0% |
| FY2017 | $176.8M | +37.5% |
| FY2016 | $128.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice